Comments
-
Patients v Pharma in access fight
- 14 Apr 2021
In this David versus Goliath battle, a high-profile advocate is pulling out everything she has to secure a win for patients.
Read more -
This can’t be right!
- 07 Apr 2021
Consecutive News Corp campaigns deciding which drugs and tests should get funded? Industry, government and patients need to resist such media campaigns.
Read more -
Did Aust suffer Covid med shortages?
- 31 Mar 2021
The TGA and companies say yes but the Productivity Commission found little evidence.
Read more -
Costly resub pathways? You asked for it!
- 25 Mar 2021
Paying $240,000 to take a year for the PBAC to consider a resubmission for a drug or vaccine deemed to offer high added value doesn’t sound that fast but apparently that’s what industry asked for.
Read more -
Migraine drugs finally on the move
- 25 Mar 2021
Lilly moving to take up the PBAC’s revised offer for Emgality.
Read more -
Access hearings an Aussie BBQ
- 17 Mar 2021
Why were the women in one session and the men in another?
Read more -
Trust is high but so is risk
- 05 Mar 2021
Comment: Pharma is caught up in a high risk reputational game.
Read more -
Humorous banter at Zimmerman inquiry
- 18 Feb 2021
Health bureaucrats and MPs showed their funny sides but has Covid hijacked the inquiry?
Read more -
A little knowledge is a dangerous thing
- 18 Feb 2021
Are knowledge and the intense focus on vaccines fuelling unrealistic expectations?
Read more